Published in Am J Physiol Lung Cell Mol Physiol on March 31, 2006
No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med (2008) 1.46
Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells. Immunology (2008) 1.38
Differentiated murine airway epithelial cells synthesize a leukocyte-adhesive hyaluronan matrix in response to endoplasmic reticulum stress. J Biol Chem (2008) 1.08
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer. Front Immunol (2015) 1.06
High-molecular-weight hyaluronan--a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats. Crit Care (2008) 1.00
Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. J Inflamm (Lond) (2008) 0.96
Hyaluronan - a functional and structural sweet spot in the tissue microenvironment. Front Immunol (2015) 0.93
Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway. J Inflamm (Lond) (2013) 0.89
Beta defensin-2 is reduced in central but not in distal airways of smoker COPD patients. PLoS One (2012) 0.88
Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor. Am J Respir Cell Mol Biol (2011) 0.83
Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease. Immunobiology (2014) 0.80
Hyaluronic acid as a rescue therapy for trinitrobenzene sulfonic acid-induced colitis through Cox-2 and PGE2 in a Toll-like receptor 4-dependent way. J Zhejiang Univ Sci B (2011) 0.77
Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation. Exp Lung Res (2015) 0.75
Decreased lung hyaluronan in a model of ARDS in the rat: effect of an inhibitor of leukocyte elastase. Ups J Med Sci (2012) 0.75
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant (2008) 7.10
The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity (2009) 6.86
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol (2011) 5.22
Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med (2009) 4.59
Role of LAG-3 in regulatory T cells. Immunity (2004) 4.36
Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol (2005) 3.74
Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol (2006) 3.32
Regulation of immune responses by mTOR. Annu Rev Immunol (2011) 3.08
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood (2007) 2.69
A role for mammalian target of rapamycin in regulating T cell activation versus anergy. J Immunol (2007) 2.53
Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant (2010) 2.17
Anergic T cells are metabolically anergic. J Immunol (2009) 2.12
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood (2010) 1.99
Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proc Natl Acad Sci U S A (2011) 1.86
mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev (2012) 1.74
The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation. Immunity (2010) 1.64
A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. Immunity (2011) 1.58
Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiation. J Immunol (2009) 1.45
A clinician's guide to the diagnosis and treatment of interstitial lung diseases. South Med J (2007) 1.43
mTOR: taking cues from the immune microenvironment. Immunology (2009) 1.38
Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol (2008) 1.35
Th2 cytokines associated with chronic rhinosinusitis with polyps down-regulate the antimicrobial immune function of human sinonasal epithelial cells. Am J Rhinol (2008) 1.21
mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation. J Clin Invest (2015) 1.18
Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol (2007) 1.18
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor. Cancer Immunol Immunother (2011) 1.16
Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med (2009) 1.15
Retracted Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways. Nat Immunol (2013) 1.09
Sleep quality and health-related quality of life in idiopathic pulmonary fibrosis. Chest (2008) 1.09
Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res (2005) 1.09
Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells. J Immunol (2012) 1.08
The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J Immunol (2004) 1.08
Disruption of Id1 reveals major differences in angiogenesis between transplanted and autochthonous tumors. Cancer Cell (2003) 1.08
Advanced visualization of airways with 64-MDCT: 3D mapping and virtual bronchoscopy. AJR Am J Roentgenol (2007) 1.07
Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med (2011) 1.00
Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. Mol Immunol (2009) 0.98
Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcription. J Immunol (2006) 0.98
Antioxidant components of naturally-occurring oils exhibit marked anti-inflammatory activity in epithelial cells of the human upper respiratory system. Respir Res (2011) 0.96
The cigarette smoke component acrolein inhibits expression of the innate immune components IL-8 and human beta-defensin 2 by sinonasal epithelial cells. Am J Rhinol (2008) 0.96
Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced. Drugs (2014) 0.96
Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression. J Inflamm (Lond) (2008) 0.96
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse. Blood (2007) 0.96
PI3K/mTOR signaling regulates prostatic branching morphogenesis. Dev Biol (2011) 0.96
The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. Am J Respir Cell Mol Biol (2008) 0.95
De novo DNA methylation is required to restrict T helper lineage plasticity. J Biol Chem (2012) 0.94
Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia. Pulm Circ (2012) 0.94
Pulmonary vaccination as a novel treatment for lung fibrosis. PLoS One (2012) 0.91
All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells. Front Immunol (2012) 0.91
Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest (2014) 0.90
Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transplant (2014) 0.89
Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor. Laryngoscope (2007) 0.89
Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway. J Inflamm (Lond) (2013) 0.89
Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis. Chest (2013) 0.89
Sensing the immune microenvironment to coordinate T cell metabolism, differentiation & function. Semin Immunol (2013) 0.87
Adenosine and anergy. Autoimmunity (2007) 0.86
Source of biomass cooking fuel determines pulmonary response to household air pollution. Am J Respir Cell Mol Biol (2014) 0.84
Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function. Am J Physiol Lung Cell Mol Physiol (2013) 0.83
Hyaluronan fragments promote inflammation by down-regulating the anti-inflammatory A2a receptor. Am J Respir Cell Mol Biol (2011) 0.83
NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages. J Biol Chem (2002) 0.82
Identification of the molecular mechanism by which TLR ligation and IFN-gamma synergize to induce MIG. Clin Dev Immunol (2004) 0.82
Quieting T cells with Slfn2. Nat Immunol (2010) 0.81
An Fc domain protein-small molecule conjugate as an enhanced immunomodulator. J Am Chem Soc (2014) 0.80
Genetic and biochemical regulation of CD4 T cell effector differentiation: insights from examination of T cell clonal anergy. Immunol Res (2010) 0.80
Exploring functional in vivo consequences of the selective genetic ablation of mTOR signaling in T helper lymphocytes. Methods Mol Biol (2012) 0.79
Regulation of CD4⁺ and CD8⁺ effector responses by Sprouty-1. PLoS One (2012) 0.78
Slc7a5 helps T cells get with the program. Nat Immunol (2013) 0.77
Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles. J Immunol (2013) 0.77
Author reply: To PMID 22986377. Ann Intern Med (2013) 0.75
Respiratory CSI: diagnosing occupationally related lung disease. South Med J (2008) 0.75
Targeted immunosuppression: no longer naïve. Clin Immunol (2011) 0.75
Correction: Immunological Priming Requires Regulatory T Cells and IL-10-Producing Macrophages To Accelerate Resolution from Severe Lung Inflammation. J Immunol (2016) 0.75
Characterization of a portable method for the collection of exhaled breath condensate and subsequent analysis of metal content. Environ Sci Process Impacts (2013) 0.75